Journal of diabetes and its complications
-
J. Diabetes Complicat. · Mar 2021
Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
To analyze therapeutic inertia in type 2 diabetes (T2D) subjects with suboptimal glycemic control and treated with ≥2 non-insulin antidiabetic agents in a primary care setting. ⋯ Therapeutic inertia occurred in over 40% of subjects. Treatment intensification took longer and was performed at higher HbA1c than recommended in clinical guidelines. Reducing therapeutic inertia is a priority to achieve therapeutic goals and prevent chronic complications in T2D.